Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Number of patients potentially eligible for proton therapy.
Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T, Blomquist E, Johansson B, Karlsson M, Zackrisson B. Glimelius B, et al. Among authors: ask a. Acta Oncol. 2005;44(8):836-49. doi: 10.1080/02841860500361049. Acta Oncol. 2005. PMID: 16332591
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN study.
Zackrisson B, Nilsson P, Kjellén E, Johansson KA, Modig H, Brun E, Nyman J, Friesland S, Reizenstein J, Sjödin H, Ekberg L, Lödén B, Mercke C, Fernberg JO, Franzén L, Ask A, Persson E, Wickart-Johansson G, Lewin F, Wittgren L, Björ O, Björk-Eriksson T. Zackrisson B, et al. Among authors: ask a. Radiother Oncol. 2011 Jul;100(1):41-8. doi: 10.1016/j.radonc.2010.12.010. Epub 2011 Feb 3. Radiother Oncol. 2011. PMID: 21295880 Clinical Trial.
Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
Zackrisson B, Kjellén E, Söderström K, Brun E, Nyman J, Friesland S, Reizenstein J, Sjödin H, Ekberg L, Lödén B, Franzén L, Ask A, Wickart-Johansson G, Lewin F, Björk-Eriksson T, Lundin E, Dalianis T, Wennerberg J, Johansson KA, Nilsson P. Zackrisson B, et al. Among authors: ask a. Radiother Oncol. 2015 Oct;117(1):99-105. doi: 10.1016/j.radonc.2015.09.024. Epub 2015 Sep 29. Radiother Oncol. 2015. PMID: 26427805 Clinical Trial.
Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
Nyqvist J, Fransson P, Laurell G, Hammerlid E, Kjellén E, Franzén L, Söderström K, Wickart-Johansson G, Friesland S, Sjödin H, Brun E, Ask A, Nilsson P, Ekberg L, Björk-Eriksson T, Nyman J, Lödén B, Lewin F, Reizenstein J, Lundin E, Zackrisson B. Nyqvist J, et al. Among authors: ask a. Radiother Oncol. 2016 Feb;118(2):335-41. doi: 10.1016/j.radonc.2015.12.024. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777124 Clinical Trial.
Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.
Hofland KF, Hansen S, Sorensen M, Engelholm S, Schultz HP, Muhic A, Grunnet K, Ask A, Costa JC, Kristiansen C, Thomsen C, Poulsen HS, Lassen U. Hofland KF, et al. Among authors: ask a. Acta Oncol. 2014 Jul;53(7):939-44. doi: 10.3109/0284186X.2013.879607. Epub 2014 Jan 23. Acta Oncol. 2014. PMID: 24456504 Clinical Trial.
61 results